OUR TECHNOLOGY
Our core business is plant-molecular pharming of recombinant proteins. Recombinant proteins (monoclonal antibodies, proteins, and enzymes) can be used as research or diagnostic reagents and, under GMP compliance regulations, as therapeutic or vaccine candidates.
Our transient plant-based expression technology provides unique benefits compared to traditional expression systems such as mammalian cell culture systems.
Click on the button below to learn more about our Technology.
PARTNERING NATURE AND HEALTH
ABOUT US
Founded in 2018, Cape Bio Pharms (Pty Ltd) is the holding company for the group of Cape Biologix Technologies companies; Cape Biologix Technologies (SA) and Cape Biologix Technologies (MAU).
With its headquarters in Cape Town, South Africa, Cape Bio Pharms drives innovation for the group by conducting product and process research, developing and owning the group's intellectual property. We also provide shared services (Finance, HR, IT, Procurement, etc) to our production subsidiaries.
For Investor Relations queries, please email investments@capebiopharms.com.
PIONEERS IN PLANT-BASED EXPRESSION
OUR PRODUCTS
Our ISO 13485 certified production subsidiaries provide a range of high quality recombinant proteins at affordable prices for customers all around the world.
Their services include product sales anywhere between small and large scale quantities, as well as R&D and OEM Agreements.
Click on the button below to explore our product range.
IN THE NEWS
PARTNERS
GET IN TOUCH
Please feel free to contact us via any of the options below, or by completing the form on the right.
​
-
General Queries: sales@capebiopharms.com
-
Investor Relations: investments@capebiopharms.com
-
Recruitment: people@capebiopharms.com
-
Reception: +27 21 286 2835.
LOCATION:
Unit 3, The Powder Mill
5 Sunrise Circle, Ndabeni, 7405
Cape Town, South Africa
Follow us on Social Media: